Risk factor
Very high price volatility
Profitability factor
Somewhat favourable analyst view
About
Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides pharmaceutical research and development services to the life sciences industry in North America, Europe, Mainland China, rest of Asia, and internationally. The company operates through five segments: Laboratory Services; Chemistry, Manufacturing and Controls (CMC) Services; Clinical Development Services; Biologics and Cell and Gene Therapy Services; and...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair value on
Target Price
The average target price of 300759.SZ is 36 and suggests 24% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Buy
Sell